Fig. 4From: Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe diseasePeak anti-recombinant human acid α-glucosidase (anti-rhGAA) antibody titers in relation to genotype. Pie charts of the distribution of antibody titer groups across patients with (n = 15) and without (n = 7) the c.-32-13 T > G (IVS1) variantBack to article page